Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009.

Canonica GW, Bousquet J, Casale T, Lockey RF, Baena-Cagnani CE, Pawankar R, Potter PC, Bousquet PJ, Cox LS, Durham SR, Nelson HS, Passalacqua G, Ryan DP, Brozek JL, Compalati E, Dahl R, Delgado L, van Wijk RG, Gower RG, Ledford DK, Filho NR, Valovirta EJ, Yusuf OM, Zuberbier T, Akhanda W, Almarales RC, Ansotegui I, Bonifazi F, Ceuppens J, Chivato T, Dimova D, Dumitrascu D, Fontana L, Katelaris CH, Kaulsay R, Kuna P, Larenas-Linnemann D, Manoussakis M, Nekam K, Nunes C, O'Hehir R, Olaguibel JM, Onder NB, Park JW, Priftanji A, Puy R, Sarmiento L, Scadding G, Schmid-Grendelmeier P, Seberova E, Sepiashvili R, Solé D, Togias A, Tomino C, Toskala E, Van Beever H, Vieths S.

Allergy. 2009 Dec;64 Suppl 91:1-59. doi: 10.1111/j.1398-9995.2009.02309.x. No abstract available.

2.

Sublingual immunotherapy in the treatment of children.

Pham-Thi N, de Blic J, Scheinmann P.

Allergy. 2006;61 Suppl 81:7-10. Review.

3.

GA² LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma.

Zuberbier T, Bachert C, Bousquet PJ, Passalacqua G, Walter Canonica G, Merk H, Worm M, Wahn U, Bousquet J.

Allergy. 2010 Dec;65(12):1525-30. doi: 10.1111/j.1398-9995.2010.02474.x. Epub 2010 Sep 7. Review.

4.

Oral lyophilisate and food immunotherapy: from research to clinical practice.

Tabar AI.

Allergol Immunopathol (Madr). 2008 Sep-Oct;36(5):277-9.

PMID:
19080800
5.

Sublingual immunotherapy for children: Are we there yet? Defining its role in clinical practice.

Campbell DE.

Paediatr Respir Rev. 2009 Jun;10(2):69-74; quiz 74. doi: 10.1016/j.prrv.2009.02.003. Epub 2009 Apr 16.

PMID:
19410205
6.

[New administration routes for immunotherapy].

Martorell Aragonés A.

Allergol Immunopathol (Madr). 2000 May-Jun;28(3):93-102. Review. Spanish.

PMID:
10867377
7.

Recommendations for appropriate sublingual immunotherapy clinical trials.

Casale TB, Canonica GW, Bousquet J, Cox L, Lockey R, Nelson HS, Passalacqua G.

J Allergy Clin Immunol. 2009 Oct;124(4):665-70. doi: 10.1016/j.jaci.2009.07.054. Epub 2009 Sep 19. Review.

PMID:
19766297
8.

Age and indications to SLIT.

Terracciano L, Calcinai E, Avitabile S, Galli E.

Int J Immunopathol Pharmacol. 2009 Oct-Dec;22(4 Suppl):5-8. Review.

PMID:
19944002
9.

An evidence based overview of sublingual immunotherapy in children.

Scala G, Di Rienzo Businco A, Ciccarelli A, Tripodi S.

Int J Immunopathol Pharmacol. 2009 Oct-Dec;22(4 Suppl):23-6. Review.

PMID:
19944006
10.

A short assessment of sublingual immunotherapy.

Rakoski J, Wessner D.

Int Arch Allergy Immunol. 2001 Nov;126(3):185-7. Review. No abstract available.

PMID:
11752874
11.

Perspectives on allergen-specific immunotherapy in childhood: an EAACI position statement.

Calderon MA, Gerth van Wijk R, Eichler I, Matricardi PM, Varga EM, Kopp MV, Eng P, Niggemann B, Nieto A, Valovirta E, Eigenmann PA, Pajno G, Bufe A, Halken S, Beyer K, Wahn U; European Academy of Allergy and Clinical Immunology..

Pediatr Allergy Immunol. 2012 Jun;23(4):300-6. doi: 10.1111/j.1399-3038.2012.01313.x. Review.

PMID:
22594930
12.

[Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].

Ibáñez Sendín MD.

Allergol Immunopathol (Madr). 2000 May-Jun;28(3):82-9. Review. Spanish.

PMID:
10867375
13.

Immunotherapy: clinical trials--optimal trial and clinical outcomes.

Bousquet PJ, Demoly P, Passalacqua G, Canonica GW, Bousquet J.

Curr Opin Allergy Clin Immunol. 2007 Dec;7(6):561-6. Review.

PMID:
17989535
14.

Novel approaches in treating food allergy using allergens.

Rancé F.

Nestle Nutr Workshop Ser Pediatr Program. 2009;64:157-63; discussion 164-7, 251-7. doi: 10.1159/000235789. Epub 2009 Aug 19. Review.

PMID:
19710521
15.

Immunotherapy: new guidelines suggest a 'window' for prevention.

[No authors listed]

Dis Manag Advis. 2003 Apr;9(4):59-61, 50.

PMID:
12751144
16.

Evaluation of the antiinflammatory and clinical effects of sublingual immunotherapy with carbamylated allergoid in allergic asthma with or without rhinitis. A 12-month perspective randomized, controlled, trial.

La Grutta S, Arena A, D'Anneo WR, Gammeri E, Leonardi S, Trimarchi A, Platania D, La Rosa M.

Eur Ann Allergy Clin Immunol. 2007 Feb;39(2):40-4.

PMID:
17441414
17.

Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both.

Purello-D'Ambrosio F, Gangemi S, Isola S, La Motta N, Puccinelli P, Parmiani S, Savi E, Ricciardi L.

Allergy. 1999 Sep;54(9):968-73.

18.

Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.

Pipet A, Botturi K, Pinot D, Vervloet D, Magnan A.

Respir Med. 2009 Jun;103(6):800-12. doi: 10.1016/j.rmed.2009.01.008. Epub 2009 Feb 12. Review.

19.

Fatalities following allergen immunotherapy.

Borchers AT, Keen CL, Gershwin ME.

Clin Rev Allergy Immunol. 2004 Oct;27(2):147-58. Review.

PMID:
15576898
20.

Therapeutics in food allergy: the current state of the art.

Otsu K, Fleischer DM.

Curr Allergy Asthma Rep. 2012 Feb;12(1):48-54. doi: 10.1007/s11882-011-0235-2. Review.

PMID:
22101989

Supplemental Content

Support Center